One-year unplanned readmission after percutaneous coronary intervention in ST-elevation myocardial infarction: rates,

O Alkhalaila1, A Rahhal2, M Altermanini1

  • 1Cardiology Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Insights

Unplanned readmissions after percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) occurred in 11.5% of patients within one year. Female gender, chronic kidney disease, multiple stents, and heart failure predicted readmission.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Unplanned readmissions post-PCI for STEMI impact healthcare systems.
  • Limited data exists on long-term readmission rates and causes.
  • No prior studies have examined PCI readmissions in STEMI patients in the Arab Gulf region.

Purpose of the Study:

  • To determine the rates, causes, and predictors of one-year unplanned readmissions post-PCI in STEMI patients.
  • To provide region-specific data from Qatar, an Arab Gulf country.

Main Methods:

  • Retrospective cohort study of 1,257 STEMI patients undergoing PCI.
  • Data collected from January 2016 to September 2018 at Hamad Medical Corporation, Qatar.
  • Patients categorized based on experiencing one or more unplanned readmissions within one year.

Main Results:

  • The all-cause readmission rate was 11.5% within one year, with 8.2% due to cardiac causes.
  • Predictors for all-cause readmission included female gender (aOR=4.14), chronic kidney disease (aOR=2.76), multiple stents (aOR=1.66), and heart failure (aOR=2.36).

Conclusions:

  • The study identified key predictors of one-year readmission in STEMI patients post-PCI.
  • Findings underscore the need for targeted management strategies for high-risk individuals to reduce readmission rates.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.1K